Malaria Vaccine

WHO approves Mosquirix as first malaria vaccine: Why this is being touted as a 'historic moment'

The vaccine developed by Britain’s GlaxoSmithKline shows a 30 percent efficacy in preventing severe cases of the mosquito-borne disease in children

World Malaria Day 2019: Despite unprecendented success, half the world's population still at risk

As of 2017, India accounted for only 4 percent of all the malaria cases reported worldwide.

World's first licensed malaria vaccine launched in three African countries

WHO intends to include 3,60,000+ kids annually from 3 African countries in the RTS,S pilot program.

Malaria vaccine offers durable protection in human trials

An experimental malaria vaccine has been found to protect a small number of healthy people from infection for more than one year after immunisation, says a study.